This company has positioned itself as a Major and the stock is completely oversold! I see a big Pharma stepping in and hitching MYL to their train for the future of the BIOSIM universe that is about to explode!! Sanofi, GSK, Sandoz
Mylan MYL came down in latest sell-off near 52 week lows however its portfolio is expanding rapidly with 2 small buys they landed for a great deal! The wild card is their entry into Biosims which Amgen is rapidly expanding internally to fight off patent expirations. Mylan will bring Amgen front and center and capture the Lion's share of the errupting BIOSIM market!! MYL could easily fetch $75-80/share buout and this would stabilize and give terrific long term growth to AMGEN as they lead the PACK in the Biotech/BIOSIM future!!